(Reuters) - Only half of patients at high risk of heart disease are given the right targets for cutting their cholesterol and millions may suffer heart attack or stroke due to doctors' poor advice, scientists said on Thursday.
Sanofi-Aventis and Merck agreed to reforge ties in animal health, combining the French drugmaker's Merial unit and Merck's Intervet/Schering Plough to take the top spot in the $19 billion market.
Asian shares failed to hold on to their early gains, slipping into negative territory as worries about Greece and the outlook for the global economy made investors cautious.
The three major U.S. indices ended mixed on Wednesday. In the morning, the stock market rallied on U.S. economic data and encouraging developments from Greece.
U.S. stocks ended little changed on Wednesday as worries about bank regulation and a setback for drug company Pfizer offset signs of improvement in the labor market and services sector.
U.S. stocks lost gains and were trading little changed on Wednesday as the White House stepped up its efforts to overhaul healthcare and bank regulation, sparking concerns about the potential impact on profits in those sectors.
The S&P 500 Index pared morning gains as health care stocks drag down the index after President Obama's remarks on efforts to pass the health care hill.
U.S. stocks rose on Wednesday after data on U.S. private employment and the vast services sector reassured investors nervous about the pace of economic recovery.
Stocks rose on Wednesday after data on the labor market and the U.S. services sector encouraged investors who had been uncertain about the pace of economic recovery.
U.S. stocks rose on Wednesday after separate reports showed private employers cut fewer jobs in February and the U.S. services sector grew at its fastest pace in more than two years.
U.S. stock index futures pointed to a higher open on Wednesday as a report showed private employers cut fewer jobs in February, adding to optimism ahead of a critical employment report later in the week.
U.S. stock index futures were little changed on Wednesday as investors awaited data on the labor market for clues ahead of a critical employment report and Greece took steps to meet fiscal targets.
U.S. stock index futures were little changed on Wednesday as investors awaited data on the labor market for clues ahead of a critical employment report and Greece took steps to meet fiscal targets.
Pfizer Inc is set to present a nearly $4 billion offer for German generic-drug maker Ratiopharm GmbH this week, competing against rival bids from Teva Pharmaceutical Industries Ltd and Actavis, sources familiar with the situation said on Tuesday.
Pfizer Inc is set to join the bidding for German generic-drug maker Ratiopharm GmbH, offering as much as 3 billion euros, Bloomberg reported on Tuesday.
Bapineuzumab -- being developed by Pfizer Inc, Irish drugmaker Elan Corp and Johnson & Johnson -- is a potential game-changer because it could be the first drug to treat the underlying cause of the degenerative brain disease.
Bayer's outgoing finance chief said the German drugs-to-chemicals company would not put its current credit rating at risk even if it launched a multi-billion euro takeover.
Merck & Co posted quarterly revenue ahead of analysts' estimates on Tuesday, and stuck by its financial goals from its recently completed merger with rival drugmaker Schering-Plough Corp.
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin said late Thursday he was resigning effective June 30 after five years as head of one of the most powerful lobby groups in Washington.
Stocks mostly fell on Wednesday as Pfizer's disappointing outlook weighed on the health sector, and President Obama's pledge to complete banking and healthcare reform revived fears of increased regulation.
Stocks mostly fell on Wednesday as Pfizer's disappointing outlook weighed on the health sector, and President Obama's pledge to complete banking and healthcare reform revived fears of increased regulation.
The stock market ended lower on Wednesday, snapping a two day rally while the dollar reversed its two day slide.
